Page 354 - ATP-P 11th Ed

• Hepatobiliary disorders
° Hepatic steatosis
° Hepatitis
° Increased liver enzymes (most commonly AST, ALT gamma GT)
° Jaundice
• Skin and subcutaneous tissue disorders
° Rash
• Musculoskeletal and connective tissue disorders
° Rhabdomyolysis
° Osteomalacia (manifested as bone pain and which may contribute to fractures), mus-
cular weakness, myopathy
• Renal and urinary disorders
° Acute renal failure
° Nephrogenic diabetes insipidus
° ° Renal insufficiency
SECTION 3 • General disorders and administration site conditions
Proteinuria
Polyuria
°
Fatigue
°
Other notes: Store at 77° F (25° C), excursions permitted to 59–86° F (15–30° C).
TMEP use: HIV Post Exposure Prophylaxis Protocol

®
Tylenol – See Acetaminophen
®
Valium – See Diazepam
®
Ventolin – See Albuterol Inhaler
Versed – See Midazolam
®
®
Viagra – See Sildenafil
®
Viread – See Tenofovir
Viracept – See Nelfinavir
®
®
Xylocaine – See Lidocaine HCI
Z-Pak – See Azithromycin
®
344 SECTION 3 RECOMMENDED DRUG LIST (RDL)